Serina Therapeutics, Inc. ($SER)
Filing Information
| Accession Number | 0001301120-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 22, 2026 |
| Document Date | Jan 20, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
12,000
Total Value
$12,380.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Jan 20, 2026 | Exercise/Conversion | 2,000 | $0.06 | $120.00 | 2,000 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Jan 20, 2026 | Sale | 2,000 | $3.07 | $6,140.00 | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Jan 21, 2026 | Exercise/Conversion | 2,000 | $0.06 | $120.00 | 2,000 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Jan 21, 2026 | Sale | 2,000 | $3.00 | $6,000.00 | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (right to buy) | Derivative | Jan 20, 2026 | Exercise/Conversion | 2,000 | $0.00 | $0.00 | 330,686 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (right to buy) | Derivative | Jan 21, 2026 | Exercise/Conversion | 2,000 | $0.00 | $0.00 | 328,686 | Direct | โ | View Details |